Literature DB >> 3680503

Human adenine phosphoribosyltransferase. Identification of allelic mutations at the nucleotide level as a cause of complete deficiency of the enzyme.

Y Hidaka1, T D Palella, T E O'Toole, S A Tarlé, W N Kelley.   

Abstract

This study reports the first demonstration of specific mutations leading to human adenine phosphoribosyltransferase (APRT) deficiency. The molecular basis of the deficiency was investigated by determining the sequence of both alleles of a patient with a complete deficiency in APRT activity. A trinucleotide deletion, corresponding to phenylalanine on the deduced amino acid sequence, was confirmed on one allele. A single nucleotide insertion, immediately adjacent to the splice site at the 5' end of the fourth intervening sequence, was confirmed on the other allele. This insertion lead to aberrant splicing, as was demonstrated by the absence of exon 4 in the complementary DNA sequence and by altered RNase mapping analysis of the abnormal messenger RNA.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3680503      PMCID: PMC442397          DOI: 10.1172/JCI113219

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  The identification of 2,8-dihydroxyadenine, a new component of urinary stones.

Authors:  H A Simmonds; K J Van Acker; J S Cameron; W Snedden
Journal:  Biochem J       Date:  1976-08-01       Impact factor: 3.857

2.  Sequence requirements for splicing of higher eukaryotic nuclear pre-mRNA.

Authors:  M Aebi; H Hornig; R A Padgett; J Reiser; C Weissmann
Journal:  Cell       Date:  1986-11-21       Impact factor: 41.582

3.  Purine enzyme abnormalities: a four year experience.

Authors:  I H Fox
Journal:  Adv Exp Med Biol       Date:  1977       Impact factor: 2.622

4.  [A new metabolic disease: the complete deficit of adenine phosphoribosyltransferase and lithiasis of 2,8-dihydroxyadenine].

Authors:  P Cartier; M Hamet; J Hamburger
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1974-09

5.  Adenine phosphoribosyltransferase: a simple spectrophotometric assay and the incidence of mutation in the normal population.

Authors:  L A Johnson; R B Gordon; B T Emmerson
Journal:  Biochem Genet       Date:  1977-04       Impact factor: 1.890

6.  Complete deficiency of adenine phosphoribosyltransferase. Report of a family.

Authors:  K J Van Acker; H A Simmonds; C Potter; J S Cameron
Journal:  N Engl J Med       Date:  1977-07-21       Impact factor: 91.245

7.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

8.  Assignment of the gene for adenine phosphoribosyltransferase to human chromosome 16 by mouse-human somatic cell hybridization.

Authors:  J A Tischfield; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

9.  Adenine phosphoribosyltransferase deficiency: a previously undescribed genetic defect in man.

Authors:  W N Kelley; R I Levy; F M Rosenbloom; J F Henderson; J E Seegmiller
Journal:  J Clin Invest       Date:  1968-10       Impact factor: 14.808

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  30 in total

1.  Effect of 5' splice site mutations on splicing of the preceding intron.

Authors:  M Talerico; S M Berget
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

2.  Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment.

Authors:  M Krawczak; D N Cooper
Journal:  Hum Genet       Date:  1991-03       Impact factor: 4.132

Review 3.  Exploring the genetic basis of early-onset chronic kidney disease.

Authors:  Asaf Vivante; Friedhelm Hildebrandt
Journal:  Nat Rev Nephrol       Date:  2016-01-11       Impact factor: 28.314

4.  Mechanisms of insertional mutagenesis in human genes causing genetic disease.

Authors:  D N Cooper; M Krawczak
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

5.  Identification of a common nonsense mutation in Japanese patients with type I adenine phosphoribosyltransferase deficiency.

Authors:  A Sahota; J Chen; K Asaki; H Takeuchi; P J Stambrook; J A Tischfield
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

6.  In vivo recognition of a vertebrate mini-exon as an exon-intron-exon unit.

Authors:  D A Sterner; S M Berget
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

7.  Alpha 1-antitrypsin deficiency caused by the alpha 1-antitrypsin Nullmattawa gene. An insertion mutation rendering the alpha 1-antitrypsin gene incapable of producing alpha 1-antitrypsin.

Authors:  D Curiel; M Brantly; E Curiel; L Stier; R G Crystal
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

8.  Identification of a compound heterozygote for adenine phosphoribosyltransferase deficiency (APRT*J/APART*Q0) leading to 2,8-dihydroxyadenine urolithiasis.

Authors:  N Kamatani; S Kuroshima; H Yamanaka; S Nakashe; H Take; M Hakoda
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

9.  Identification of two new aberrant splicings in the ornithine carbamoyltransferase (OCT) gene in two patients with early and late onset OCT deficiency.

Authors:  T Matsuura; R Hoshide; S Komaki; K Kiwaki; F Endo; S Nakamura; T Jitosho; I Matsuda
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

10.  Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype.

Authors:  I Santisteban; F X Arredondo-Vega; S Kelly; A Mary; A Fischer; D S Hummell; A Lawton; R U Sorensen; E R Stiehm; L Uribe
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.